These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 9873118

  • 1. Side effects of acne therapy and their management.
    Miller RA.
    J Cutan Med Surg; 1998 May; 2 Suppl 3():14-8. PubMed ID: 9873118
    [No Abstract] [Full Text] [Related]

  • 2. Analysis of laboratory data in acne patients treated with isotretinoin: is there really a need to perform routine laboratory tests?
    Alcalay J, Landau M, Zucker A.
    J Dermatolog Treat; 2001 Mar; 12(1):9-12. PubMed ID: 12171680
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Watery eye: a new side-effect of isotretinoin therapy.
    Chua WC, Martin PA, Kourt G.
    Eye (Lond); 2001 Feb; 15(Pt 1):115-6. PubMed ID: 11318276
    [No Abstract] [Full Text] [Related]

  • 6. Utility of studying the ocular surface in patients with acne vulgaris treated with oral isotretinoin: a randomized controlled trial.
    Aragona P, Cannavò SP, Borgia F, Guarneri F.
    Br J Dermatol; 2005 Mar; 152(3):576-8. PubMed ID: 15787837
    [No Abstract] [Full Text] [Related]

  • 7. Isotretinoin-induced nail fragility and onycholysis.
    Onder M, Oztaş MO, Oztaş P.
    J Dermatolog Treat; 2001 Jun; 12(2):115-6. PubMed ID: 12243670
    [Abstract] [Full Text] [Related]

  • 8. Acute monoarthritis in a patient under isotretinoin.
    Dubourg G, Koeger AC, Huchet B, Rozenberg S, Bourgeois P.
    Rev Rhum Engl Ed; 1996 Mar; 63(3):228-9. PubMed ID: 8731245
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Acute hip monoarthritis in a patient treated with isotretinoin.
    Pedraz T, Martínez A, Pascual E.
    J Clin Rheumatol; 2006 Apr; 12(2):105-6. PubMed ID: 16601552
    [No Abstract] [Full Text] [Related]

  • 12. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris.
    Zane LT, Leyden WA, Marqueling AL, Manos MM.
    Arch Dermatol; 2006 Aug; 142(8):1016-22. PubMed ID: 16924051
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Isotretinoin embryopathy. Report of one case].
    Troncoso Sch M, Rojas H C, Bravo C E.
    Rev Med Chil; 2008 Jun; 136(6):763-6. PubMed ID: 18769834
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. FDA, Roche to implement new dispensing procedures for isotretinoin.
    Young D.
    Am J Health Syst Pharm; 2001 Dec 15; 58(24):2359-60. PubMed ID: 11794946
    [No Abstract] [Full Text] [Related]

  • 17. Isotretinoin treatment for acne vulgaris and its cutaneous and ocular side-effects.
    Azurdia RM, Sharpe GR.
    Br J Dermatol; 1999 Nov 15; 141(5):947. PubMed ID: 10583197
    [No Abstract] [Full Text] [Related]

  • 18. Menstrual irregularity during isotretinoin treatment.
    Kwon HJ, Lee JY, Cho BK, Park HJ.
    J Eur Acad Dermatol Venereol; 2007 Apr 15; 21(4):562-3. PubMed ID: 17374003
    [No Abstract] [Full Text] [Related]

  • 19. [Acne fulminans after the treatment with isotretinoin].
    López-Vílchez MA, Vicente Villa MA, García-Fructuoso MT, Manzanares Bahí R, González Enseñat MA.
    An Esp Pediatr; 1999 Aug 15; 51(2):200-2. PubMed ID: 10495512
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.